Antisense Technology
Genta Incorporated Announces Fourth Quarter and Year End 2006 Financial Results and Corporate Highlights
Published in Drug Law Weekly, March 6th, 2007
Company will file appeal for Genasense(R) NDA in CLL
Expanded Access Program to continue in U.S. during appeal
Completed response to EMEA 180-day review questions for MAA in melanoma; formal CHMP opinion expected within 90 days
Follow-on Genasense/melanoma trial initiated using key biomarker
Intermittent Genasense dosing shown effective in preclinical models; clinical trial of intermittent short IV and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-03-06)
More Articles from Drug Law Weekly
- Acute Myelogenous Leukemia
Vion Pharmaceuticals Enters into an Agreement to Sell Convertible Senior Notes and Warrants - Biomedical Engineering
BioMimetic Therapeutics, Inc. Announces Pricing of Public Offering - Biomedical Engineering
BioMimetic Therapeutics, Inc. Completes Public Offering of Approximately 3.25 Million Shares of Common Stock Including the Sale of All Over-Allotment Shares - Breast Cancer
Philadelphia Hormone Therapy Trial Completed - Cancer
Advanced Magnetics Announces Settlement of Lawsuit with Cytogen Corporation - Cytogen Corporation
Cytogen Announces Settlement Agreement with Advanced Magnetics - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
